Sign In
Buy NYXH
$1.57
+0 (+0%)
At Close: Jun 23, 2026
Publication relating to transparency notifications
04:30pm, Wednesday, 01'st Sep 2021
PRESS RELEASE
Nyxoah Issues First Half 2021 Financial Results
04:30pm, Tuesday, 31'st Aug 2021
REGULATED INFORMATION
Should You Buy Nyxoah (NYXH) Ahead of Earnings?
09:54am, Monday, 30'th Aug 2021
Nyxoah (NYXH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Nyxoah Appoints Rita Johnson-Mills to its Board of Directors
04:30pm, Friday, 27'th Aug 2021
Nyxoah Appoints Rita Johnson-Mills to its Board of Directors
Nyxoah to Release First Half 2021 Financial Results on August 31 and Host Earnings Conference Call on September 1, 2021
04:30pm, Wednesday, 11'th Aug 2021
Mont-Saint-Guibert, Belgium. - August 11, 2021, 10:30 pm CET / 4:30 pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the
Publication relating to a transparency notification
04:30pm, Monday, 19'th Jul 2021
PRESS RELEASE REGULATED INFO R MATION
Publication relating to a transparency notification
04:30pm, Wednesday, 14'th Jul 2021
PRESS RELEASE
Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters' Full Exercise of Option to Purchase Additional Shares
04:30pm, Thursday, 08'th Jul 2021
REGULATED INFORMATION INSIDE INFORMATION
Nyxoah Announces Pricing of Nasdaq Public Offering
08:40am, Friday, 02'nd Jul 2021
Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the dev
